ARCHIVES

After ODAC: Questions On ESA Claims, Advertising, Reimbursement Gain Urgency.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

NIH Defines Misconduct

December 9, 1994

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

Also in this 8-page issue: John Mendelsohn selected for BMS award. National Coalition for Cancer Survivorship and The Wellness Community begin advocacy initiative.

March 19, 2004

Tumor Cells In Blood May Indicate Aggressive Cancer

April 25, 2003

If You Were On ODAC: Experts Suggest Questions For May 10 Advisory Meeting.

March 16, 2007

Funding Opportunities.

June 7, 2002